Advertisement

Topics

Population Diagnostics, Inc. Company Profile

22:09 EST 27th February 2017 | BioPortfolio

Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medicine tests. PDx’s technology, which reveals the genetic causes of complex diseases such as autism, diabetes, Parkinson’s, and Alzheimer’s, enables development of early detection diagnostic tests that predict pre-symptomatically why some individuals will suffer from debilitating diseases while others will not. When applied to drug discovery, the technology enables pharmaceutical companies to develop targeted therapies and companion diagnostics. Its novel technology and exclusive products places PDx in a prime position to (i) transform how physicians diagnose and manage disease in their patients and (ii) enable pharmaceutical companies to expand the number of available therapies and market drugs with higher efficacy and safety.


News Articles [1161 Associated News Articles listed on BioPortfolio]

Thermo Fisher Competitive Position, Sales and Market Shares by Country and Product Prices from USD $4250

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Chembio to buy Malaysia’s RVR Diagnostics

US-based Chembio Diagnostics has agreed to acquire Malaysian firm RVR Diagnostics.

EUROIMMUN partners with Angsana Molecular & Diagnostics on allergy diagnostics and testing in Singapore

EUROIMMUN (SEA) and Angsana Molecular & Diagnostics announced a strategic partnership on the allergy diagnostics and testing to support clinicians, hospitals and private laboratories in South East Asi...

Cerner Emphasizes Population Health but Pay Attention to the Details

Support for population health is a major strategic goal in the EHR world but what exactly does the term mean? The topic commands considerable mindshare for Cerner which has created a special landing p...

EUROIMMUN (SEA) partners with Angsana Molecular Diagnostics on Allergy Diagnostics and Testing ...

SINGAPORE--(Marketwired - Nov 21, 2016) - EUROIMMUN (SEA)and Angsana Molecular & Diagnostics today build a strategic partnership on the allergy diagnostics and testing to Read more...

2016 US Infectious Disease Testing Market: Sales and Market Shares of Major Suppliers by Test Prices from USD $6500

This unique report from VPGMarketResearch provides US sales and market share estimates for major suppliers of infectious disease testing products by assay and country.The report also presents strategi...

Deals this week: Exosome Diagnostics, D.Western Therapeutics Institute, ProMIS Neurosciences

Biofluid-based diagnostics provider Exosome Diagnostics has signed an agreement with Merck to help advance the development of new drugs in oncology and other therapeutic areas using the former’s pro...

SystemOne, Daktari collaborate to improve value of diagnostics

SystemOne and Daktari Diagnostics have partnered to bring connected diagnostics to developing world.

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [1989 Associated PubMed Articles listed on BioPortfolio]

Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.

The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.

Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the US, 2000-2013.

 Treatment of Neisseria gonorrhoeae infection is empiric and based on population-wide susceptibilities. Increasing antimicrobial resistance underscores the potential importance of rapid diagnostics,...

Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders.

The growing number of identified genetic disease risk variants across dog breeds challenges the current state-of-the-art of population screening, veterinary molecular diagnostics, and genetic counseli...

Characteristics of lymphoproliferative disorders with more than one aberrant cell population as detected by 10-color flow cytometry.

We have evaluated the frequency of lymphoproliferative disorders with more than one aberrant population of monotypic B-cells detected during routine hematopathological diagnostics.

Exploring the Case for a Global Alliance for Medical Diagnostics Initiative.

In recent years, the private and public sectors have increased investments in medical diagnostics for low- and middle-income countries (LMICs). Despite these investments, numerous barriers prevent the...

Clinical Trials [1289 Associated Clinical Trials listed on BioPortfolio]

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes

Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have been made in pacemaker therapy, diagnostics and connectivity. These advancements include autom...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions

The "Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions (RACE-IT)" represents a mono-centric registry of patients being hospitalized su...

Companies [1158 Associated Companies listed on BioPortfolio]

Population Genetics Technologies Ltd

Population Genetics Technologies Ltd was founded in 2005 by Nobel Laureate Dr Sydney Brenner; by Dr Sam Eletr, a founder of Applied Biosystems and of Lynx Therapeutics; and by Dr ...

Veterinary Diagnostics Institute (VDxI), Inc.

VDxI, a California corporation, is a veterinary clinical ventures company dedicated to the introduction of innovative biomarkers for companion animals. Through collaboration with ...

The Population Health Alliance

The Population Health Alliance (PHA) is a global trade association of the population health industry. Its more than 80 members represent stakeholders from across the health care d...

Population Diagnostics, Inc.

Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medici...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

More Information about "Population Diagnostics, Inc." on BioPortfolio

We have published hundreds of Population Diagnostics, Inc. news stories on BioPortfolio along with dozens of Population Diagnostics, Inc. Clinical Trials and PubMed Articles about Population Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Population Diagnostics, Inc. Companies in our database. You can also find out about relevant Population Diagnostics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Autism
Autism affects half a million people in the UK. Men are affected more than women. People with autism have said that the world, to them, is a mass of people, places and events which they struggle to make sense of, and which can cause them considerable a...


Corporate Database Quicklinks



Searches Linking to this Company Record